Tower Research Capital (TRC)’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-5,794
Closed -$99.4K – 5666
2025
Q4
$99.4K Buy
5,794
+5,294
+1,059% +$53.8K ﹤0.01% 1949
2025
Q3
$2.63K Sell
500
-9,495
-95% -$42.6K ﹤0.01% 4604
2025
Q2
$41.8K Buy
9,995
+9,895
+9,895% +$62.1K ﹤0.01% 3122
2025
Q1
$1.4K Sell
100
-1,473
-94% -$25.8K ﹤0.01% 4713
2024
Q4
$44.2K Buy
+1,573
New +$135K ﹤0.01% 2630

Other funds holding MSTZ

Tower Research Capital (TRC)'s MSTZ Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q1 2026, closing a stake of 5,794 shares — an estimated $99.4K sold.

Tower Research Capital (TRC) first reported a position in MSTZ in Q4 2024 and held it in 5 quarters. The position peaked at $99.4K in Q4 2025. 16 funds tracked by Wall St. Rank hold MSTZ as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining T-Rex 2X Inverse MSTR Daily Target ETF position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,794 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q1 2026, an estimated $99.4K.
  • Tower Research Capital (TRC) first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q4 2024 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $99.4K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.